Department of Radiology and Nuclear Medicine, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, location University of Amsterdam, Office G1-229, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
Neuroradiology. 2023 Jun;65(6):1053-1061. doi: 10.1007/s00234-023-03139-4. Epub 2023 Mar 8.
Intravenous alteplase (IVT) prior to endovascular treatment (EVT) is neither superior nor noninferior to EVT alone in acute ischemic stroke patients. We aim to assess whether the effect of IVT prior to EVT differs according to CT perfusion (CTP)-based imaging parameters.
In this retrospective post hoc analysis, we included patients from the MR CLEAN-NO IV with available CTP data. CTP data were processed using syngo.via (version VB40). We performed multivariable logistic regression to obtain the effect size estimates (adjusted common odds ratio a[c]OR) on 90-day functional outcome (modified Rankin Scale [mRS]) and functional independence (mRS 0-2) for CTP parameters with two-way multiplicative interaction terms between IVT administration and the studied parameters.
In 227 patients, median CTP-estimated core volume was 13 (IQR 5-35) mL. The treatment effect of IVT prior to EVT on outcome was not altered by CTP-estimated ischemic core volume, penumbral volume, mismatch ratio, and presence of a target mismatch profile. None of the CTP parameters was significantly associated with functional outcome after adjusting for confounders.
In directly admitted patients with limited CTP-estimated ischemic core volumes who presented within 4.5 h after symptom onset, CTP parameters did not statistically significantly alter the treatment effect of IVT prior to EVT. Further studies are needed to confirm these results in patients with larger core volumes and more unfavorable baseline perfusion profiles on CTP imaging.
在急性缺血性脑卒中患者中,静脉内阿替普酶(IVT)联合血管内治疗(EVT)并不优于单独 EVT。我们旨在评估 IVT 联合 EVT 前的效果是否因 CT 灌注(CTP)成像参数而异。
本回顾性事后分析纳入了 MR CLEAN-NO IV 研究中具有 CTP 数据的患者。使用 syngo.via(版本 VB40)处理 CTP 数据。我们进行多变量逻辑回归,以获得 CTP 参数的效应大小估计值(调整后的共同优势比 a[c]OR),包括 90 天功能结局(改良 Rankin 量表[mRS])和功能独立性(mRS 0-2),以及 IVT 给药与研究参数之间的双向乘法交互项。
在 227 例患者中,CTP 估计的核心体积中位数为 13(IQR 5-35)mL。IVT 联合 EVT 对结局的治疗效果不受 CTP 估计的缺血核心体积、半暗带体积、不匹配比和目标不匹配特征的影响。在调整混杂因素后,没有任何 CTP 参数与功能结局显著相关。
在直接入院且 CTP 估计的缺血核心体积较小的患者中,在症状发作后 4.5 小时内接受治疗,CTP 参数并未显著改变 IVT 联合 EVT 前的治疗效果。需要进一步研究来确认这些结果在 CTP 成像上具有更大核心体积和更不利的基线灌注特征的患者中是否成立。